Grace Halsey

The phase 3 EMPA-KIDNEY clinical trial had just met prespecified criteria for positive efficacy when the study's Independent Data Monitoring Committee recommended the early halt.

A new meta-analysis questions the science demonstrating the link between statin-induced LDL-C lowering and improved CV, all-cause outcomes.

COVID-19 accelerated telehealth as a standard option but what services will it be best suited for now? A new survey suggests the future.

Individuals with migraine were found more likely to have IBS and IBS was more prevalent in those with migraine; both associations were statistically significant.

The direct oral anticoagulant was associated with a lower rate of rehospitalization for VTE among patients extending anticoagulation beyond 90 days, investigators report.

Increasing alcohol intake from 1 to 2 drinks per day was associated with brain changes equivalent to aging 2 years, according to a study of more than 36 000.

Findings for atogepant from the phase 3 PROGRESS study will form the basis of a submission by AbbVie to FDA for a label expansion in the US.

Consider migraine screening for all women aged 20 to 50 years, suggests Ailani; you'll likely find a majority of them have migraine. More pearls follow.

Migraine-specific preventive therapies should be in the primary care toolbox, according to headache specialist Jessica Ailani, MD.

Migraine headache specialist and researcher Jessica Ailani, MD, fully supports primary care as the setting for the majority of the treatment for the disease.

Routine point-of-care AF screening in primary care using a handheld ECG device proved feasible but increased diagnoses only in patients aged ≥85 years, in the VITAL-AF study.

Drops in flu vaccine coverage this season have been recorded among young children and pregnant people and racial/ethnic gaps in uptake continue, says CDC.

Tara Carr, MD, led a post hoc analysis of the NAVIGATOR phase 3 trial and presented data on tezepelumab efficacy in the vulnerable subgroup at the AAAAI 2022 meeting.

Findings on use of acute and preventive migraine therapy continue to reveal gaps with far more patients eligible than the proportions using either type.

Glycemic variability and low time in range were associated with retinopathy, nephropathy, neuropathy, and CVD in a cohort of more than 20 000 persons, most with T2D.

When choosing a migraine treatment for acute attack relief, the American Headache Society suggests following these steps.

Tezepelumab, a TSLP inhibitor, reduced asthma exacerbation rates in patients with severe uncontrolled disease across a range of respiratory comorbidities.

Patients with asthma who did require hospitalization for SARS-CoV-2 infection were at greater risk for intubation and remdesivir treatment, a new study reports.

The landmark approval for the SGLT-2 inhibitor will open access to treatment for the ~ 3 million adults with heart failure with preserved ejection fraction.

In the PATH-BP study, use of acetaminophen 4g/day increased BP among patients with hypertension by nearly 5 mm Hg within 2 weeks of beginning the regimen.

t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.

In the majority of studies that reported racial/ethnic data, White participants were highly overrepresented and Black/Hispanic/all Other underrepresented.

US patients at high CV risk do not receive adequate evidence-based pharmacotherapy, according to large multisite cohort analysis.

Among persons who survived COVID-19, a new study found a 60% increased risk for any new mental health diagnosis during the year following infection.

Recommendations on hypertension management from the US Surgeon General's office are summarized for at-a-glance American Heart Month reading.

The CDC is inviting public feedback on updated recommendations for opioid prescribing for the first time since the controversial 2016 iteration.

The 2022 DSMES National Standards update focuses on reducing administrative burden on educators and improving person-centered care for patients.

The 50 states and DC are ranked by longest and shortest life expectancy at birth and at age 65 years and by the difference in life expectancy between men and women.

The 180-day sensor life doubles the period of continuous use and cuts in half the number of CGM removals and reinsertions, without loss of accuracy.

The 5-year cumulative relapse rate among early quitters was nearly 40% in a large international cohort of stroke patients, according to an abstract presented at ISC22.